UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Rituximab plus cyclophosphamide and dexamethasone versus bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial

Haematologica (Roma), 2024-05, Vol.109 (5), p.1614

2024

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance

American journal of roentgenology (1976), 2022-02, Vol.218 (2), p.310

2022

Link zum Volltext

Verfügbarkeit prüfen

CNCT19 CAR T-Cell Therapy in Relapsed or Refractory B-Cell Lymphoma: Long-Term Results of a Pilot Prospective Clinical Study

Blood, 2022-11, Vol.140 (Supplement 1), p.4598-4599

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Activity of Combining CNCT19 with HDT/ASCT in Refractory Large B-Cell Lymphoma: Two-Year Follow-up of a Prospective Phase 1/2 Clinical Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.7472-7473

2022

Link zum Volltext

Verfügbarkeit prüfen

Zanubrutinib Plus Ixazomib and Dexamethasone for Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Prospective, Phase II Study

Blood, 2022-11, Vol.140 (Supplement 1), p.3587-3588

2022

Link zum Volltext

Verfügbarkeit prüfen

Total Tumor ADC Histogram Analysis: A New Tool for Predicting High-Risk Cytogenetic Abnormalities in Multiple Myeloma Patients

Academic radiology, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Anti-CD19 CAR T Therapy Following Autologous HSCT May be Safe and Effective in Patients with Refractory Large B-Cell Lymphoma

Blood, 2019-11, Vol.134 (Supplement_1), p.784-784

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of GBC/GBM Conditioning Regimen Followed By Autologous Stem Cell Transplantation in Lymphoid Malignancies

Blood, 2020-11, Vol.136 (Supplement 1), p.14-15

2020

Link zum Volltext

Verfügbarkeit prüfen

Anti-CD19 CAR T-Cell (CNCT19) Infusion Following HDT/ASCT Is Safe and Effective in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Blood, 2020-11, Vol.136 (Supplement 1), p.2-2

2020

Link zum Volltext

Verfügbarkeit prüfen

A Simple Risk-Scoring Model for Estimating the Prognostic Impact of 1q Gain in Patients with Newly-Diagnosed Multiple Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.4360-4361

2022

Link zum Volltext

Verfügbarkeit prüfen

R-DA-Edoch/R-DHAP Alteration Could Overcome High Risk Factors in Younger Mantle Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.6512-6513

2022

Link zum Volltext

Verfügbarkeit prüfen

A Retrospective, Matched Paired Analysis Comparing GBM/GBC Versus BEAM/Beac Conditioning Regimen for Autologous Stem Cell Transplantation in Non-Hodgkin's Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.10585-10586

2022

Link zum Volltext

Verfügbarkeit prüfen

The Risk of Hepatitis B Reactivation Is Controllable in Patients with Concomitant Hepatitis B Virus Infection during Chimeric Antigen Receptor T-Cell Therapy

Blood, 2019-11, Vol.134 (Supplement_1), p.2913-2913

2019

Link zum Volltext

Verfügbarkeit prüfen

Purine Nucleoside Analogs Plus Rituximab Is an Effective Treatment Choice for Hairy Cell Leukemia-Variant: Results from a Single Center in China

Blood, 2021-11, Vol.138 (Supplement 1), p.3547-3547

2021

Link zum Volltext

Verfügbarkeit prüfen

Rituximab Maintenance Benefits Less for Follicular Lymphoma Patients with Low Risk of the Follicular Lymphoma International Index

Blood, 2021-11, Vol.138 (Supplement 1), p.3544-3544

2021

Link zum Volltext

Verfügbarkeit prüfen

Thalidomide Plus Prednisone and Methotrexate for Symptomatic Large Granular Lymphocyte Leukemia: A Prospective, Single-Center, Pilot Study

Blood, 2020-11, Vol.136 (Supplement 1), p.23-24

2020

Link zum Volltext

Verfügbarkeit prüfen

Minimal Residual Disease Assessment Is an Independent Prognostic Factor in Splenic Marginal Zone Lymphoma

Blood, 2020-11, Vol.136 (Supplement 1), p.2-2

2020

Link zum Volltext

Verfügbarkeit prüfen

Novel Insight into Multi-Hit Multiple Myeloma Based on “Two-Hit” Theory of Cancer Causation

Blood, 2020-11, Vol.136 (Supplement 1), p.47-48

2020

Link zum Volltext

Verfügbarkeit prüfen

Genomic and Transcriptomic Profiling Reveals Distinct Subsets Associated with Outcomes in Mantle Cell Lymphoma

Blood, 2020-11, Vol.136 (Supplement 1), p.28-29

2020

Link zum Volltext

Verfügbarkeit prüfen

A Synthetic Regression Model for Large Portfolio Allocation

Journal of business & economic statistics, 2022-10, Vol.40 (4), p.1665-1677

2022

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of thin InAlAs digital alloy avalanche photodiodes

Optics letters, 2021-08, Vol.46 (16), p.3841-3844

2021

Link zum Volltext

Verfügbarkeit prüfen

FOXA2 activates HIF2α expression to promote tumor progression and is regulated by the E3 ubiquitin ligase VHL in renal cell carcinoma

The Journal of biological chemistry, 2024-01, Vol.300 (1), p.105535-105535, Article 105535

2024

Link zum Volltext

Verfügbarkeit prüfen

Preferences for participation in shared decision-making among cataract patients in urban southern China: a cross-sectional study

The Lancet (British edition), 2016-10, Vol.388, p.S56-S56

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Blood
(16)
Academic Radiology
(1)
American Journal Of Roentgenology
(1)
Haematologica
(1)
Journal Of Business & Economic Statistics
(1)
Optics Letters
(1)
The Journal Of Biological Chemistry
(1)
The Lancet
(1)

3 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Rituximab plus cyclophosphamide and dexamethasone versus bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial

Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance

CNCT19 CAR T-Cell Therapy in Relapsed or Refractory B-Cell Lymphoma: Long-Term Results of a Pilot Prospective Clinical Study

Long-Term Activity of Combining CNCT19 with HDT/ASCT in Refractory Large B-Cell Lymphoma: Two-Year Follow-up of a Prospective Phase 1/2 Clinical Trial

Zanubrutinib Plus Ixazomib and Dexamethasone for Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Prospective, Phase II Study

Total Tumor ADC Histogram Analysis: A New Tool for Predicting High-Risk Cytogenetic Abnormalities in Multiple Myeloma Patients

Anti-CD19 CAR T Therapy Following Autologous HSCT May be Safe and Effective in Patients with Refractory Large B-Cell Lymphoma

Safety and Efficacy of GBC/GBM Conditioning Regimen Followed By Autologous Stem Cell Transplantation in Lymphoid Malignancies

Anti-CD19 CAR T-Cell (CNCT19) Infusion Following HDT/ASCT Is Safe and Effective in Patients with Relapsed/Refractory Large B-Cell Lymphoma

A Simple Risk-Scoring Model for Estimating the Prognostic Impact of 1q Gain in Patients with Newly-Diagnosed Multiple Myeloma

R-DA-Edoch/R-DHAP Alteration Could Overcome High Risk Factors in Younger Mantle Cell Lymphoma

A Retrospective, Matched Paired Analysis Comparing GBM/GBC Versus BEAM/Beac Conditioning Regimen for Autologous Stem Cell Transplantation in Non-Hodgkin's Lymphoma

The Risk of Hepatitis B Reactivation Is Controllable in Patients with Concomitant Hepatitis B Virus Infection during Chimeric Antigen Receptor T-Cell Therapy

Purine Nucleoside Analogs Plus Rituximab Is an Effective Treatment Choice for Hairy Cell Leukemia-Variant: Results from a Single Center in China

Rituximab Maintenance Benefits Less for Follicular Lymphoma Patients with Low Risk of the Follicular Lymphoma International Index

Thalidomide Plus Prednisone and Methotrexate for Symptomatic Large Granular Lymphocyte Leukemia: A Prospective, Single-Center, Pilot Study

Minimal Residual Disease Assessment Is an Independent Prognostic Factor in Splenic Marginal Zone Lymphoma

Novel Insight into Multi-Hit Multiple Myeloma Based on “Two-Hit” Theory of Cancer Causation

Genomic and Transcriptomic Profiling Reveals Distinct Subsets Associated with Outcomes in Mantle Cell Lymphoma

A Synthetic Regression Model for Large Portfolio Allocation

Characteristics of thin InAlAs digital alloy avalanche photodiodes

FOXA2 activates HIF2α expression to promote tumor progression and is regulated by the E3 ubiquitin ligase VHL in renal cell carcinoma

Preferences for participation in shared decision-making among cataract patients in urban southern China: a cross-sectional study

Aktive Filter

Suchergebnisse filtern